BRD4-BD1-IN-2

HY-143300

BRD4-BD1-IN-2

BRD4-BD1-IN-2 is a selective BRD4-BD1 inhibitor, with an IC50 of 2.51 µM (20-times greater than that of BD2). BRD4-BD1-IN-2 can be used in studies of cancer and cardiovascular diseases[1].

Ask for quotation

T64117-10mg

BRD4-BD1-IN-2

BRD4-BD1-IN-2

Ask for quotation

T64117-1g

BRD4-BD1-IN-2

BRD4-BD1-IN-2

Ask for quotation

6662-30T

BRD3-BD2 Antibody

412.8 €

32513

BRD3 (BD1) Inhibitor Screening Assay Kit

The BRD3 (BD1) Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD3 bromodomain 1 (BD1) from binding to its substrate. The key to the BRD3 (BD1) Inhibitor Screening Assay Kit is the highly specific binding of the BRD3 bromodomain 1 to the acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD3 bromodomain 1 and an inhibitor of choice is incubated with the biotinylated substrate for thirty minutes. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

915 €

32519

BRD9 (BD1) Inhibitor Screening Assay Kit

The BRD9 Inhibitor Screening Assay Kit is designed to measure the inhibition of BRD9 binding to its substrate. The key to the BRD9 Inhibitor Screening Assay Kit is the specific binding of the BRD9 bromodomain to an acetylated histone substrate. With this kit, only three simple steps on a microtiter plate are required. First, a sample containing BRD9 and an inhibitor of choice is incubated with the biotinylated substrate. Next, acceptor beads are added, then donor beads, followed by reading the Alpha-counts.

915 €